 CB2R mainly distributed in hippocampal neurons under normal conditions;  The expression of CB2R significantly increased and time-dependently changed post status epilepticus (SE);  3. CB2R may play a role at the early stage of pilocarpine-induced SE and its role is mainly through the hippocampal neurons.
A C C E P T E D M A N U S C R I P T status epilepticus (SE).
Methods: A total of 112 male Sprague-Dawley rats at three weeks of age, weighing 43 g-68.5 g, were used for this study. Rats were randomly divided into a control group (n =16) and an epilepsy a SE group. The epilepsy SE group was further divided into 6 sub-groups (2 hours, 1, 3, 7, 14, and 21 days after status epilepticus (SE)). A SE model was induced with lithium chloride and pilocarpine by intraperitoneal injection.
Hematoxylin-Eosin staining (H&E staining) and TdT-mediated dUTP nick end labeling (TUNEL staining) were used to observe neuronal necrosis and apoptosis pyroptosis in the hippocampus. Double-label immunofluorescence and Western blotting were used to detect the distribution and expression of CB2R in the rat hippocampus exposed to
SE.
Results: According to the Racine scale ， nearly 15% of the pilocarpine-induced rats showed Racine stages 1 and 2 in the epilepsy group, almost 74% of the rats showed Racine stages 3 to 5, and 11% of the rats died in the SE or post SE. Morphologically, compared with control group, the number of neurons remarkably decreased while apoptotic pyroptotic neurons in number significantly increased in the CA1, CA3 and DG regions from 2 hours to 3 days post SE by H&E and TUNEL staining, respectively (p < 0.05). Double immunofluorescence staining revealed that CB2R was mainly expressed in the CA1, CA3 and A C C E P T E D M A N U S C R I P T DG neuronal regions of the hippocampus and the number of CB2R-positive neurons significantly increased within these regions post SE as compared with the control group, particularly in the DG region.
Furthermore, the protein expression of CB2R began to be elevated from 2 hours post SE (p < 0.05) and peaked at 1, 3 and 7 days (p < 0.01), respectively peaked at 1 day and high levels were maintained at days 3 and 7 (p < 0.01 for all of them). After that, the protein expression of CB2R gradually declined with by time interval.
Conclusions:
We demonstrate that CB2R is expressed in hippocampal neurons and time-dependently expressed changed post SE, suggesting that the role of CB2R is mainly through hippocampal neurons at the early stage of pilocarpine-induced SE. CB2R may play a role at the early stage of pilocarpine-induced SE and its role is mainly through the hippocampal neurons.
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Introduction
Epilepsy is a chronic neurological disorder, characterized by an enduring predisposition to generate epileptic seizures, and by the neurobiologic, cognitive, psychological, and social consequences of this condition. (Fisher et al., 2014) . Particularly in early life, seizures can be attributed to a significant cause of morbidity. Almost one third of infants and children with epilepsy fail to achieve seizure remission when treating with current antiepileptic drugs (AEDs). Status epilepticus (SE) is the severest form of epilepsy, a severe condition with significant morbidity or mortality. SE is characterized by a seizure with 5 minutes or more of continuous clinical and/or electrographic seizure activity, or recurrent seizure activity without recovery between seizures according to The Neurocritical Care Society guidelines from 2012 (Meletti et al., 2018) . Therefore, there's is a tremendous need for preventing and repairing brain damage and to explore the mechanism by which neuronal damage and repair occur following SE.
The endocannabinoid system is composed of specific cannabinoid receptors (cannabinoid receptor type 1, CB1R; cannabinoid receptor type 2, CB2R), endocannabinoids, and enzymes for the biosynthesis and degradation of endocannabinoids. Cannabinoid receptors are a part of the
receptors, CB1R and CB2R are the most frequently studied. Previous studies reported that CB1R is abundantly expressed in the central nervous system (CNS) (Jansen et al., 1992) , whereas CB2R is mainly expressed in the cells and organs of the immune system (Glass and Northup, 1999) .
Recent studies have demonstrated that CB2R is also expressed in the central nervous system CNS under normal conditions, such as as in cerebral cortex neurons (SKAPERSkaper et al., 1996) , hippocampus and globus pallidus neurons (Lanciego et al., 2011) , brainstem neurons (Viscomi et al., 2005) . Furthermore, substantial evidence from animal experiments suggests that CB2R is also expressed in the neurons of the central nervous system (CNS) during a variety of pathological conditions, such as methamphetamine-induced dopaminergic neurotoxicity (Nader et al., 2014) , drug abuse and depression (Onaivi et al., 2008) , neuropathic pain (Svíženská I.H., 2013) , anxiety, depression and alcohol preference (Liu Q.R., 2017) .
The endocannabinoid system plays a crucial role in the epileptogenesis of the hippocampus. Aghaei et al. (2015) reported that palmitoylethanolamide (PEA, a fatty acid amide compound) could extend the latency and shorten the duration of a seizure through CB1R and CB2R in a pentylenetetrazol (PTZ, a GABA receptor angonist)-induced seizure model (Aghaei et al., 2015) . Additionally, Fujii et al. (2014) A C C E P T E D M A N U S C R I P T demonstrated that activation of CB2R by JWH-133 attenuated neuronal apoptosis by activation of phosphorylated CREB-Bcl-2 pathway in the a Subarachnoid Hemorrhage model (Fujii et al., 2014) . Given that neurons in the hippocampus play an important role in mediating the occurrence and development of epilepsy, and Lanciego et al. (2011) reported that CB2R is expressed in the hippocampus (Lanciego et al., 2011) , but the roles of CB2R in the process of epilepsy are not elucidated. Therefore, the aim of the study is to investigate the distribution and time-dependent expression of CB2R in hippocampus after SE in rats, which is expected to obtain a preliminary insight into the functions of CB2R at the early stage of SE.
Materials and methods

Animal model of status epilepticus
All animal experiments were conducted in accordance with to the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals (NIH Publications No. 8023, revised 1978) A reproducible SE model in rats was induced as previously described (Curia et al., 2008) . All rats were randomly divided into a control group (n = 16) and an experimental group (SE, n = 96). The SE group was further divided into 6 sub-groups (n = 16 per subgroup): 2 hours, 1, 3, 7, 14 and 21 days post SE onset. Rats were first given lithium chloride (3 mEq/kg intraperitoneal (i.p.)). After 16-18 hours, they were injected with methyl scopolamine (1 mg/kg, i.p., Sigma, USA) in order to reduce peripheral cholinergic effects. Thirty minutes later, rats of the experimental group were treated with pilocarpine hydrochloride (30 mg/kg, i.p., Sigma, USA) to induce SE while control animals received a comparable volume of saline. Behavioral seizures were evaluated every 15 minutes according to the Racine scale (Racine, 1972) . Status Epilepticus (SE) was defined as continuous seizures with a Racine score of level 3 to 5 for at least 5 minutes. Approximately 30 minutes after pilocarpine injection, most of the rats achieved SE, which was allowed to last for 30 minutes. Diazepam (10 mg/kg, i.p.) was administered 30 minutes after the onset of SE to limit behavioral seizures and reduce mortality. If no seizures were produced within 30 min in the Pilocarpine-injected pilocarpine-injected rats, an additional 10 mg/kg dose of pilocarpine was given every 30 minutes until a seizure occurred or the maximum dose of 60 mg/kg was reached. Rats were sacrificed by
injection of 3% sodium pentobarbital (30 mg/kg) and were perfused through the left ventricle with normal saline (NS) at different time points according to their groups or sub-groups. In each group or sub-group, the intact brain tissue of 6 rats was taken for morphological evaluation and the hippocampus of the other 6 rats was molecular biological detection.
H&E and TUNEL staining Hematoxylin-Eosin staining (H&E staining) and TdT-mediated dUTP nick end labeling (TUNEL staining)
Brain tissue was fixed in 4% paraformaldehyde at room temperature and then embedded in paraffin. 4-μm-thick coronal sections were subsequently prepared for morphological evaluation. The sections were deparaffinized in xylene, hydrated with a series of graded alcohol.
TUNEL staining was performed according to manufacturer instructions and H&E staining was conventionally conducted. The number of necrotic neurons in 3 low-power fields of each H&E-stained slide were counted.
For TUNEL-positive cells evaluation, 10 microscopic fileds were randomly selected at 200-fold magnification in CA1, CA3 and DG regions.
Double-label immunofluorescence
The sections were deparaffinized in xylene, hydrated with a series of graded alcohol, and then heated in a microwave oven for antigen retrieval (with 0.01 mol/L sodium citrate buffer, pH 6.0). The sections were then 
Protein extraction and western blotting assay
The hippocampus samples were immersed in RIPA buffer (KGP9100, KeyGEN BioTECH, Nanjing, China), which contained protease and phosphatase inhibitors at 4°C, broken up using a tissue grinding pestle and then homogenized with a sonicator. Homogenates were centrifuged at 14,000× g for 15 minutes at 4°C and the liquid supernatant was collected for each sample. Protein concentrations were detected using the Enhanced The reactive bands were detected by using chemiluminescent substrate kit (Thermo WP20005, MA, USA) and with a ProtoBlot II AP system using a stabilized substrate (Promega). GAPDH was used for the controls. A densitometric analysis of the bands was performed and were semi-quantitatively conducted using Scion Image software (Scion Corporation, MD, USA).
Statistical analysis
Data was analyzed as mean ± standard deviation (mean ± SD) and a one-way analysis of variance (ANOVA) was applied, and followed by the LSD post hoc multiple comparison test using SPSS 18.0 for Windows (SPSS, Chicago, IL, USA). P < 0.05 was considered statistically significant difference.
Results
Establishment of animal model for SE
The behavioral progression of epileptic seizures was monitored after lithium-pilocarpine treatment, and had a latency period of 10-20 minutes after pilocarpine injection. SeizuresSE duration was limited to 30 or 60 minutes by diazepam administration. Control rats treated only with Saline saline did not develop seizures. Experimental rats were classified according to the Racine scale (Racine, 1972) . In our experiment, nearly 15% of the pilocarpine-induced rats showed Racine stage 1 and 2; almost 74% of the rats showed Racine stage 3 to 5, and 11% of rats died in the SE or post SE. The rats which presented continuous seizures from Racine stage 3 to 5 were selected as the experimental group.
Neuronal loss in the hippocampus after SE
H&E staining was used to detect the morphological changes of neurons in the hippocampus. Compared with the control group, edema, degeneration and necrosis of neurons accompanied by a significant decrease in number of neurons could be observed in the CA1, CA3 and A C C E P T E D M A N U S C R I P T DG regions from 2 hours to 3 days after SE (p < 0.05). Besides, nuclear deviation, cytoplasm condensed and nuclear fragmented of neurons could also be observed in these regions. (Fig. 1) . (Fig. 2) . 
Double indirect immunofluorescence analyses
To detect the distribution of CB2R in hippocampus under normal conditions and post SE, double indirect immunoflourescence was conducted. The CB2R-positive neurons could be observed in CA1, CA3 and DG regions under normal conditions and post SE. The localization of CB2R mainly located in the cytomembrane in neurons with part of its expression occurring in the cytoplasm (Figs. 3-5) . Furthermore, the number of CB2R-positive neurons was up-regulated within 7 days and down-regulated thereafter. There were significant differences between control group and 2 hours, 1, 3 and 7 days (p < 0.05) post SE in the CA1, CA3 and DG regions. Besides, the number of CB2R-positive neurons
peaked at 1 day (p < 0.01) in all the three regions after SE as compared with the control group (Fig. 6) . Interestingly, CB2R+/GFAP+ cells could not be detected and only small number of CB2R+/IBA-1+ cells could be observed in the hippocampal CA1, CA3 and DG regions under normal conditions and post SE (Fig. S1, S2) . In negative controls, little green fluorescence was seen and weak auto-fluorescence was observed in CA1, CA3 and DG regions (Fig. S3) . 
Western blotting assay
The protein expression of CB2R can be was detected in all specimens including the control by Western blotting. Its expression was up-regulated within 7 days (p < 0.05) and down-regulated thereafter， which maximized peaking at 1, 3 and 7 days (p < 0.01) post SE as compared with control group. There were significant differences in the relative intensity of CB2R to GAPDH between control group and 2 hours, 1, 3 and 7 days post SE. Relative intensity of CB2R to GAPDH. Significant increases in the relative protein levels of CB2R to GAPDH were observed at 2 hours, 1, 3, 7, 14 and 21 days post SE as compared with that of control and at 2 hours, 1, 14 and 21 days as compared with their previous groups. Data are presented as mean ± SD. *p < 0.05, **p < 0.01(vs control group); #P < 0.05 (vs previous SE group).
Discussion
Epilepsy is a common neurological disorder characterized by recurrent seizures (Hauser et al., 1993) . Temporal Lobe Epilepsy (TLE) is the most common form of epilepsy in adults, possibly caused by a primary brain injury in childhood (Curia et al. 2014) . Recurrent seizures during childhood can cause progressive brain damage, especially the hippocampus damage. It was reported that epileptogenesis involves mainly extended neuronal death and reactive gliosis to cause neural network reorganization, accompanied by a number of cellular and molecular events including alterations in brain circuitry, changes in gene expression, neurochemical alterations in receptors and neurotransmitters (Jensen, 2009; Jacobs et al., 2009) Accumulated data demonstrated that CB2R is expressed in neurons of rodent central nervous system CNS (Lanciego et al., 2011; SKAPER Skaper et al., 1996; Viscomi et al., 2005) . Furthermore, it was reported that CB2R is expressed in rodent hippocampal neurons, particularly in postsynaptic compartments of CA3/2 fields (Huizenga et al., 2017) . In this study, we further demonstrated that CB2R is expressed in hippocampal neurons, and its protein expression was up-regulated post SE. Although the role of CB2R in neurons has not yet been fully elucidated, several studies had reported that CB2R participates in neuroinflammation, synaptic plasticity (Stempel et al., 2016) and drug abuse (Gertsch et al., 2008; Mansouri et al., 2014) . It was reported that cannabinoids and their analogues through CB2R had been found to display a neuroprotective effect against alcohol addiction inflammation (Gertsch et al., 2008; Mansouri et al., 2014) , depression (Katsuyama et al., 2013) , cerebral ischemia (Choi et al., 2013 ) and Alzheimer's disease (Cheng et al., 2014) . Furthermore, it was reported that WIN 55, 212-2, which is a mixed CB1/2 agonist, presents anti-convulsant effects in tonic-clonic seizures evoked by PTZ and acute hypoxia-induced seizures
while antagonism CB2R by specific antagonist AM630 increases seizure severity of rats in PTZ-evoked seizure model (Huizenga et al., 2017) .
Additionally, Tchekalarova et al. (2018) found that the activation of CB2R by BCP can inhibit the spread of seizures (Tchekalarova et al., 2018) . Therefore, CB2R may play certain roles a role at the early stage of pilocarpine-induced SE.
Several studies reported that the functions of CB2R primarily through microglias of the central nervous system CNS ( Stollg and Jander,1999) and it is closely associated with various neuroinflammatory diseases, such as multiple sclerosis (Arévalo-Martín et al., 2003; Benito et al., 2007) , experimental autoimmune encephalomyelitis (EAE) ( Maresz et al., 2007) , stroke and brain injury (Donat et al., 2014) . Several studies revealed that microglia activation and astrocyte proliferation occurred in the hippocampus after SE onset (Pacheco et al., 2016; Schartz et al., 2016) , and CB2R expression was up-regulated in striatal microglia of Huntington's disease transgenic mouse models and patients to play a neuroprotective role (Palazuelos et al., 2009 ). Interestingly, we did not observe the expression of CB2R in the astrocytes, and we detected only small number of microglias expressing CB2R in the hippocampal CA1, In conclusion, we demonstrate that CB2R is expressed in hippocampal neurons and time-dependently expressed changed post SE, suggesting that the functions of CB2R mainly through hippocampal neurons at the early stage of pilocarpine-induced SE. CB2R may play a role at the early stage of pilocarpine-induced SE and its role is mainly through the hippocampal neurons. Furthermore, CB2R may be a new target for the treatment of epilepsy.
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